| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	At 24 months, the target lesion primary patency (TLPP)1 was 41.7%At 24 months, the access circuit primary patency (ACPP)2 was 2...
																	Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and raises the p...
																	Piper Sandler analyst Jason Bednar reiterates Merit Medical Systems (NASDAQ:MMSI) with a Overweight and raises the price tar...
																	
																	Needham analyst Mike Matson reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $108 price target.
																	Merit Medical Systems (NASDAQ:MMSI) raises FY2025 Adj EPS guidance from $3.52-$3.72 to $3.66-$3.79 vs $3.63 analyst estimate. R...
																	Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of...